| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |